Biomerica, Inc. (NASDAQ:BMRA) Short Interest Update

Biomerica, Inc. (NASDAQ:BMRA) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 58,700 shares, a drop of 56.6% from the September 30th total of 135,100 shares. Approximately 2.2% of the company’s stock are short sold. Based on an average daily trading volume, of 845,800 shares, the short-interest ratio is currently 0.1 days. Based on an average daily trading volume, of 845,800 shares, the short-interest ratio is currently 0.1 days. Approximately 2.2% of the company’s stock are short sold.

Biomerica Trading Down 4.8%

NASDAQ:BMRA opened at $2.79 on Thursday. The firm has a market capitalization of $8.23 million, a PE ratio of -2.91 and a beta of 0.34. Biomerica has a 1 year low of $2.08 and a 1 year high of $10.16. The firm’s fifty day simple moving average is $2.96 and its 200 day simple moving average is $3.24.

Hedge Funds Weigh In On Biomerica

A hedge fund recently bought a new stake in Biomerica stock. Bulltick Wealth Management LLC bought a new stake in shares of Biomerica, Inc. (NASDAQ:BMRA) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 137,149 shares of the company’s stock, valued at approximately $78,000. Bulltick Wealth Management LLC owned 5.39% of Biomerica as of its most recent SEC filing. Hedge funds and other institutional investors own 22.28% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Biomerica in a research note on Tuesday, October 14th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.